GMO EMERGING Mutual Fund Money Managers

GMEMX Fund  USD 22.03  0.20  0.92%   
GMO EMERGING is run by 2 fund managers with a total tenure of about 3 years, averaging roughly 1.0 years of service per executive having 0.5 employees per reported executive. Fund managers are in charge of implementing GMO EMERGING MARKETS investing strategy and managing its portfolio trading activities. Break down of GMO EMERGING management performance can provide insight into the fund's overall performance. Note, fund manager's attribution analysis is becoming a valuable factor that both investors and analysts use to determine the amount of risk that may be associated with GMO EMERGING MARKETS future under-performance.
Check out Risk vs Return Analysis.
  
Arjun Divecha  Executive
Fund Manager
More  
Warren Chiang  Executive
Fund Manager
More  

GMO EMERGING Net Asset Comparison

GMO EMERGING MARKETS is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Diversified Emerging Mkts category is currently estimated at about 2.93 Billion. GMO EMERGING totals roughly 2.81 Billion in net asset claiming about 96% of all funds under Diversified Emerging Mkts category.

GMO EMERGING MARKETS Benchmark Summation

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Indexes of lowest and highest values over a specified period line shows minimum and maximum index of GMO EMERGING MARKETS price series.
.

GMO EMERGING Notable Stakeholders

A GMO EMERGING stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as GMO EMERGING often face trade-offs trying to please all of them. GMO EMERGING's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting GMO EMERGING's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About GMO EMERGING Management Performance

The success or failure of an entity such as GMO EMERGING MARKETS often depends on how effective the management is. GMO EMERGING management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of GMEMX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the GMEMX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The investment seeks total return in excess of that of its benchmark, the MSCI Emerging Markets Index. GMO Emerging is traded on NASDAQ Exchange in the United States.
The data published in GMO EMERGING's official financial statements usually reflect GMO EMERGING's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of GMO EMERGING MARKETS. For example, before you start analyzing numbers published by GMEMX accountants, it's critical to develop an understanding of what GMO EMERGING's liquidity, profitability, and earnings quality are in the context of the GMO space in which it operates.
Please note that past performance is not an indicator of the future performance of GMO EMERGING, its manager's success, or the effectiveness of its strategy. The performance results shown here may have been adversely or favorably impacted by events and economic conditions that may not prevail in the future. Therefore, you must use caution to infer that these results indicate any fund, manager, or strategy's future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost. .

GMO EMERGING MARKETS Annual Yield

In accordance with the recently published financial statements, GMO EMERGING MARKETS has an Annual Yield of 0.0%. This is 100.0% lower than that of the GMO family and about the same as Diversified Emerging Mkts (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Check out Risk vs Return Analysis. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for analysis

When running GMO EMERGING MARKETS price analysis, check to measure GMO EMERGING's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GMO EMERGING is operating at the current time. Most of GMO EMERGING's value examination focuses on studying past and present price action to predict the probability of GMO EMERGING's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move GMO EMERGING's price. Additionally, you may evaluate how the addition of GMO EMERGING to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Directory
Find actively traded corporate debentures issued by US companies
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Please note, there is a significant difference between GMO EMERGING's value and its price as these two are different measures arrived at by different means. Investors typically determine GMO EMERGING value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GMO EMERGING's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.